Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $63.0300 (2.39%) ($62.0500 - $64.1900) on Tue. Nov. 13, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.56% (three month average) | RSI | 36 | Latest Price | $63.0300(2.39%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX declines -0.1% a day on average for past five trading days. | Weekly Trend | BAX declines -3.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(57%) SPLV(53%) VYM(52%) XLP(51%) IVE(49%) | Factors Impacting BAX price | BAX will decline at least -0.78% in a week (0% probabilities). TLT(-20%) DIA(-12%) VIXM(-11%) GDXJ(-11%) VXX(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.78% (StdDev 1.56%) | Hourly BBV | 0 () | Intraday Trend | 1% | | | |
|
Resistance Level | $65.69 | 5 Day Moving Average | $63.09(-0.1%) | 10 Day Moving Average | $62.92(0.17%) | 20 Day Moving Average | $65.69(-4.05%) | To recent high | -19% | To recent low | 2.4% | Market Cap | $32.157b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |